Oxidative stress markers are elevated in exhaled breath condensate of workers exposed to nanoparticles during iron oxide pigment production by Pelclová, Daniela et al.
This content has been downloaded from IOPscience. Please scroll down to see the full text.
Download details:
IP Address: 158.196.184.56
This content was downloaded on 15/06/2016 at 13:35
Please note that terms and conditions apply.
Oxidative stress markers are elevated in exhaled breath condensate of workers exposed to
nanoparticles during iron oxide pigment production
View the table of contents for this issue, or go to the journal homepage for more
2016 J. Breath Res. 10 016004
(http://iopscience.iop.org/1752-7163/10/1/016004)
Home Search Collections Journals About Contact us My IOPscience
© 2016 IOP Publishing Ltd
D Pelclova et al
Printed in the UK
016004
JBROBW















Oxidative stress markers are elevated in exhaled breath condensate 
of workers exposed to nanoparticles during iron oxide pigment 
production
Daniela Pelclova1, Vladimir Zdimal2, Petr Kacer3, Zdenka Fenclova1, Stepanka Vlckova1, Kamila Syslova3, 
Tomas Navratil4, Jaroslav Schwarz2, Nadezda Zikova2, Hana Barosova5, Francesco Turci6, Martin Komarc7,8, 
Tomas Pelcl9, Jaroslav Belacek7, Jana Kukutschova5 and Sergey Zakharov1
1 Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Department of Occupational 
Medicine, Na Bojišti 1, 128 00 Prague 2, Czech Republic
2 Institute of Chemical Process Fundamentals of the AS CR, v.v.i., Rozvojová 1/135, 165 02 Prague 6, Czech Republic
3 Institute of Chemical Technology, Technická 5, 166 28 Prague 6, Czech Republic
4 J. Heyrovský Institute of Physical Chemistry of the AS CR, v.v.i., Dolejškova 3, 182 23 Prague 8, Czech Republic
5 Nanotechnology Centre, VSB—Technical University of Ostrava,17. Listopadu 15, 708 33 Ostrava, Czech Republic
6 Interdepartmental Centre ‘G. Scansetti’ for Studies on Asbestos and Other Toxic Particulates and NIS Interdepartmental Centre for 
Nanostructured Interfaces and Surfaces, University of Torino, Via P. Giuria 7, I-10125 Torino, Italy
7 Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Institute of Biophysics and 
Informatics, Salmovská 1, 120 00 Prague 2, Czech Republic
8 Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, Faculty of Physical Education and 
Sport, José Martího 31, 162 52 Prague 6, Czech Republic
9 Charles University in Prague and General University Hospital in Prague, First Faculty of Medicine, 3rd Medical Department,  
U Nemocnice 1, 128 08 Praha 2, Czech Republic
E-mail: daniela.pelclova@lf1.cuni.cz
Keywords: nanoparticles, Fe2O3, Fe3O4, exhaled breath condensate, urine, oxidative stress, occupational exposure
Abstract
Markers of oxidative stress and inflammation were analysed in the exhaled breath condensate (EBC) 
and urine samples of 14 workers (mean age 43  ±  7 years) exposed to iron oxide aerosol for an average 
of 10  ±  4 years and 14 controls (mean age 39  ±  4 years) by liquid chromatography-electrospray 
ionization-mass spectrometry/mass spectrometry (LC-ESI-MS/MS) after solid-phase extraction. 
Aerosol exposure in the workplace was measured by particle size spectrometers, a scanning mobility 
particle sizer (SMPS) and an aerodynamic particle sizer (APS), and by aerosol concentration 
monitors, P-TRAK and DustTRAK DRX.
Total aerosol concentrations in workplace locations varied greatly in both time and space. The 
median mass concentration was 0.083 mg m−3 (IQR 0.063–0.133 mg m−3) and the median particle 
concentration was 66 800 particles cm−3 (IQR 16 900–86 900 particles cm−3). In addition, more than 
80% of particles were smaller than 100 nm in diameter.
Markers of oxidative stress, malondialdehyde (MDA), 4-hydroxy-trans-hexenale (HHE), 
4-hydroxy-trans-nonenale (HNE), 8-isoProstaglandin F2α (8-isoprostane) and aldehydes C6–C12,
in addition to markers of nucleic acid oxidation, including 8-hydroxy-2-deoxyguanosine (8-OHdG), 
8-hydroxyguanosine (8-OHG), 5-hydroxymethyl uracil (5-OHMeU), and of proteins, such as 
o-tyrosine (o-Tyr), 3-chlorotyrosine (3-ClTyr), and 3-nitrotyrosine (3-NOTyr) were analysed in 
EBC and urine by LC-ESI-MS/MS.
Almost all markers of lipid, nucleic acid and protein oxidation were elevated in the EBC of workers 
comparing with control subjects. Elevated markers were MDA, HNE, HHE, C6–C10, 8-isoprostane, 
8-OHdG, 8-OHG, 5-OHMeU, 3-ClTyr, 3-NOTyr, o-Tyr (all p  <  0.001), and C11 (p  <  0.05). Only 
aldehyde C12 and the pH of samples did not differ between groups. Markers in urine were not elevated.
These findings suggest the adverse effects of nano iron oxide aerosol exposure and support 
the utility of oxidative stress biomarkers in EBC. The analysis of urine oxidative stress biomarkers 
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APS aerodynamic particle sizer
BMI body mass index
DNA deoxyribonucleic acid




LC-ESI-MS/MS  liquid chromatography—electrospray 
ionization—tandem spectrometry
MDA malondialdehyde
NIOSH National Institute for Occupational 
Safety and Health
NOx nitrogen oxides
OECD Organisation for Economic  
Co-operation and Development
OSHA Occupational Safety and Health 
Administration
o-Tyr o-tyrosine
PEL permissible exposure limit
PM particulate matter
PSD particle number size distribution
RNA ribonucleic acid
ROS reactive oxygen species
SMP scanning mobility particle sizer
SPE solid-phase extraction
TWA time-weighted average concentration
1. Introduction
Iron nanoparticles belong to 13 priority nanomaterial 
groups identified by the organisation for economic 
co-operation and development (OECD) for evaluation 
of their safety [1]. There is very little information about 
potential risks of occupational exposure to engineered 
nanoparticles during production and processing; 
therefore this is a widely debated issue. Studies on the 
effect of occupational exposure to engineered iron 
oxide nanoparticles have yet to be published [2] and 
no biological exposure tests have been developed to 
monitor workers’ exposure [3].
Similar to all nanoparticles, iron oxide nanoparti-
cles are associated with unique physicochemical prop-
erties that facilitate their use in novel applications. On 
the other hand, nano-scale particles with large surface 
area and enhanced reactivity can more readily dif-
fuse across biological membranes and through tissue 
barriers. Based on experimental data, humans exposed 
to engineered nanomaterials could have oxidative dam-
age in their respiratory system and in other organs due 
to systemic effects [3, 4].
Iron oxide nanoparticles, including Fe2O3 and 
Fe3O4, are found naturally in the environment during 
volcanic eruptions. In addition, they can be found in 
vehicle and industry emissions and air pollution partic-
ulates. They are also chemically synthesized for a wide 
variety of applications. For example, they are present in 
paint, ink, rubbers, plastics, cosmetics, and in medical 
devices [2].
Occupational exposure to iron oxides occurs dur-
ing pigment production. These pigments have pure 
consistent properties and tinting strength. Ilmenite 
(FeTiO3) is a steel-grey titanium-iron oxide mineral 
that is the source of iron oxides used in the pigment 
production industry. Red iron oxide pigments are 
produced by thermal decomposition in the process of 
roasting and calcination. α-Fe2O3 is obtained by oxida-
tive calcination of decomposable iron compounds. The 
colour changes from red with a decreasing yellowish 
hue between 700–750 °C to red with an increasing blu-
ish hue between 750–900 °C [5].
Single component forms are mainly produced as 
red (hematite, α-Fe2O3, 70% iron), yellow (limonite/
goethite, FeO(OH), 63% iron) and black (magnetite, 
Fe3O4, 72% iron) pigment. A combination of Fe2O3 and 
Fe3O4 yields brown pigment [6]. These production pro-
cesses generate high concentrations of small particles 
[7].
Nevertheless, the potential adverse health effects 
of iron oxide nanoparticles are poorly understood 
and limited information on the toxicological effects of 
these nanoparticles exists. However, it is now known 
that their toxicity may differ from that of their bulk 
counterparts. Experimental studies suggest that iron 
oxide nanoparticles can be distributed in secondary 
organs and induce damage in biological systems [8]. 
After inhalation, due to their small size, nanoparticles 
can deposit in the lower, gas exchange region of the 
lungs [9]. In addition, inhalation of iron oxide particles 
is more likely to have systemic effects, compared with 
ingestion and dermal exposure [2].
Nano-sized particles can directly interact with the 
plasma membrane and/or mitochondria NADPH 
oxidases, leading to disruption of the electron trans-
port chain and generation of superoxide radicals [10]. 
According to Singh [11], iron oxide nanoparticles in 
cells can be degraded into Fe2+ in lysosomes. This ‘free 
iron’ has the potential to cross nuclear and mitochon-
drial membranes. In mitochondria, Fe2+ can react with 
hydrogen peroxide and oxygen to form highly reactive 
hydroxyl radicals and Fe3+ via the Fenton reaction. The 
generation of hydroxyl radicals and other reactive oxy-
gen species (ROS) can result in lipid, protein and DNA 
damage, leading to impaired mitochondrial function, 
cellular stress, inflammation, cytotoxicity, apoptosis 
and genotoxicity [11, 12].
In rats, bronchoalveolar lavage and histopathology 
revealed decreased cell viability and lung injury fol-
lowing a single 4 h inhalation exposure to 640 mg m−3 
iron oxide nanoparticles (Fe3O4, size 15–20 nm). 
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Within 24 h post-exposure, lung tissue malondialde-
hyde (MDA) concentration increased [13]. Inhalation 
of ~20 mg m−3 Fe3O4 aerosol for 4 h led to interstitial 
inflammation and macrophage infiltration in the alveo-
lar region [9]. However, after a mild acute exposure to 
Fe2O3, Sotiriou et al [14] found significantly elevated 
levels of ROS in the lungs and hearts of rats exposed 
for 5 h to 100–200 μg m−3 Fe2O3. Systemic effects, spe-
cifically hepatic and renal injury caused by oxidative 
stress, were observed after intraperitoneal injection of 
Fe3O4 nanoparticles in mice. This mechanism was sup-
ported by an increase in tissue MDA and 8-hydroxy-
2′deoxyguanosine (8-OHdG) at doses of 20 mg kg−1 
of body weight [15]. After intravenous injection of 
γ-Fe2O3 (0.8 mg kg−1) in rats, inflammation in the 
lungs, liver and kidneys suggested small particles 
crossed endothelial barriers related to vascularisation 
and vessel permeability in these organs [4]. Similarly, 
in experimental studies on human cells, oxidative stress 
markers were elevated in lung bronchial cells, fibro-
blasts [10, 16], endothelial cells [4], and bone marrow 
mesenchymal stromal cells [17] following exposure to 
iron oxide nanoparticles.
In humans, markers of oxidative stress, MDA, 
4-hydroxy-trans-hexenale (HHE), HNE, 8-isoPros-
taglandine F2α (8-isoprostane) and aldehydes C6–C12 
are used to detect lipid oxidation [18]. Nitrotyrosine 
(3-NOTyr) is a marker for nitration stress, 3-chloro-
tyrosine (3-ClTyr) is a specific molecular marker for 
the production of chlorinating oxidants by eosinophil 
peroxidase and myeloperoxidase systems in leuko-
cytes, and o-tyrosine (o-Tyr) is an amino acid oxida-
tion biomarker. In nuclear DNA, 8-OHdG, i.e. 8-oxo-
7,8-dihydro-2′-deoxyguanosine (8-oxodG), is the 
predominant form of free radical-induced oxidative 
lesions, similar to 8-hydroxyguanosine (8-OHG) and 
hydroxymethyl uracil (5-OHMeU) in RNA. Therefore, 
several markers of oxidative stress have been widely 
used as biomarkers for oxidative stress and carcinogen-
esis, in particular lung carcinogenesis [19–21].
Besides occupational exposure, epidemiological 
studies have shown that environmental exposure to air 
pollution is associated with detrimental effects including 
disorders related to oxidative stress [22–24]. For exam-
ple, MDA was suggested as a biomarker of oxidative stress 
in the respiratory tract in relation to air pollution expo-
sure, and MDA and 8-OHdG were suggested as urine 
biomarkers for systemic oxidative stress [19, 25, 26].
Exhaled breath condensate (EBC) is a liquid that 
reflects the composition of the fluid lining the airway 
[27]. It is obtained non-invasively from subjects after 
cooling of exhaled air. EBC is composed mainly of 
water (99.9%) and a small proportion of water-soluble 
and insoluble compounds. These non-volatile com-
pounds can include small inorganic ions, large organic 
molecules (urea, organic acids, amino acids), pro-
teins and macromolecules that presumably originate 
from the airway lining fluid in the form of aerosolized 
particles [28]. The analysis of EBC allows the source of 
biomarkers, originally formed in airways and lungs, to 
be tracked.
The aim of this study was to evaluate markers of 
oxidative stress in the EBC of workers exposed to iron 
oxide nanoparticles during iron oxide pigment pro-




After work-shifts, EBC and urine samples were collected 
in 14 workers (males, 43  ±  7 years, 43% smokers). Their 
mean length of exposure to iron oxides was 10  ±  4 
years. The control group was composed of 14 males 
(39  ±  4 years, 50% smokers), who were not employed 
in this factory and were not exposed occupationally 
to dust or other health risks (safety inspectors and 
office workers). Both groups were examined according 
to the following scheme: a physical examination, a 
standardized questionnaire with questions on personal 
and occupational history, treatments, dietary habits, 
smoking habits and alcohol intake.
EBC samples were collected using Ecoscreen Turbo 
(DECCS, Jaeger, Germany). All subjects breathed 
tidally for about 15 min through a mouthpiece con-
nected to a condenser (−20 °C) while wearing a nose-
clip. A constant volume of exhaled air of 120 L was 
maintained using EcoVent device by Jaeger, Germany, 
and time of collection was about 15 min. All samples 
were immediately frozen and stored at  −80 °C.
2.1.1. Ethics 
The study was conducted according to the Declaration 
of Helsinki. The Ethical Committee of the 1st Medical 
Faculty, Charles University approved the study.
2.2. Analysis of oxidative stress markers in EBC and 
urine
MDA, HNE, HHE, 8-isoprostane, aldehydes C6–C12, 
8-OHdG, 8-OHG, 5-OHMeU, o-Tyr, 3-ClTyr and 
3-NOTyr were analysed after solid-phase extraction 
(SPE) by liquid chromatography—electrospray 
ionization—tandem spectrometry (LC-ESI-MS/
MS) using deuterium-labelled internal standards, 
as previously described [29, 30]. Conductivity was 
measured as a reference indicator in EBC dilution 
to take into account changes in respiratory solute 
concentration [31]. To exclude contamination of EBC 
by saliva, α-amylase concentration was determined 
[31]. In addition, pH has been measured [32]. 
Biomarker concentrations in urine samples were 
normalised to urinary creatinine concentration [33]. 
Furthermore, all samples were blinded to personnel 
involved in sample analysis.
2.3. Workplace aerosol measurements
Pilot measurements of total particle concentrations 
were determined to construct concentration maps, 
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localize main aerosol sources and determine locations 
of high iron oxide pigment. Total particle number 
and mass concentrations were mapped using P-Trak® 
Ultrafine Particle Counter 8525 (P-TRAK) (TSI Inc., 
Minneapolis, USA) and DustTrak™ DRX Aerosol 
Monitor 8533 (DustTrak) (TSI Inc., Minneapolis, 
USA), respectively.
For the 8-h shift samples, three locations were 
selected: (1) the calcination furnace, (2) drying units, 
and (3) the control room. These three locations were 
selected because workers frequently worked there. The 
aim of these measurements was to determine changes in 
particle size distribution during shifts to estimate work-
ers’ exposure to airborne particulates.
The instruments used were two aerosol size spectro-
meters, a Scanning Mobility Particle Sizer™ (SMPS) 
model 3936 L (TSI Inc., Minneapolis, USA), and an 
Aerodynamic Particle Sizer® Spectrometer (APS) 
model 3321 (TSI Inc., Minneapolis, USA). The aero-
sol spectrometers sampled synchronously with a 5 min 
time resolution, covering overall particle diameters 
from 15 nm–10 μm, and with a size resolution of 32 
channels/decade. As the particle size distributions 
(PSDs), measured by SMPS and APS, overlapped in 
the size range of 0.5–1 μm, the total particle number 
and mass concentration determined as a sum of these 
two instruments had to be corrected for this overlap. 
Without this correction, the error in total concentra-
tion would have been 10–25% of total concentration, 
depending on the distribution shape.
At the beginning of the work-shift, the SMPS and 
APS were placed at one of the preselected locations, 
usually several meters away from manufacturing equip-
ment and preferably at a location where workers walked 
by. After performing routine spectrometer checks, the 
SMPS and APS were left unattended while samples were 
continuously collected during 8-h shifts. For each shift, 
spectrometers were moved to different locations.
During measurements, random checks were per-
formed to compare total particle number concentra-
tions determined by SMPS and APS with P-TRAK 
values (the differences between averaged values never 
exceeded 20%). Similarly, PM10 mass concentrations 
determined by DustTrak were compared with the 
PM10 integrated from the combined SMPS and APS 
data (particle density was assumed to be 5.24 g cm−3). 
Workers spent the majority of their time in the control 
room with a closed door. The second most frequented 
area was near the calcination furnace, which emitted 
particles.
2.4. Raman spectra of dust sediment from the 
production process
Five samples of dust sediment on the workshop floor 
were collected from different stages of production, i.e. 
calcination, milling and drying during the production 
of different pigments (red, yellow and brown) and 
analysed by Raman microspectroscopy using the 
Smart Raman Microscopy System XploRATM 
(HoribaYvonJobin, France). Raman spectra were 
acquired with a 532 nm excitation laser source and 1200 
grooves mm−1 grating. Multiple parts of the samples 
were chosen for further analysis.
2.5. Environmental air contamination
Air concentrations of SO2, O3, nitrogen oxides (NOx), 
particulate matter (PM)2.5 and PM10, recorded on 
hourly basis were taken on the same days workers were 
examined. The value related to the same hour when 
the post-shift and control EBC samples were obtained. 
Air concentrations were obtained from the National 
Hydrometeorological monitoring system at the closest 
stationary monitoring station. In the case of workers, 
the distance to the site of EBC collection was 1.6 km, 
and in controls the distance was 1.5 km. The following 
analytical methods were used: UV-fluorescence (SO2), 
chemiluminiscence (NOx), UV-absorption (O3), and 
an optoelectronic method (PM).
2.6. Statistics
Basic descriptive statistics (mean, median, 
confidence interval, standard deviation, skewness, 
and kurtosis) were computed for all variables, which 
were subsequently tested for normality using the 
Kolmogorov-Smirnov test. The chi-square test was 
used to compare frequency counts of demographic 
categorical variables (smoking, and alcohol 
consumption) in groups of workers versus controls. 
Differences in interval demographic variables were 
tested using independent-groups t-test (for normally 
distributed variables) and the Mann-Whitney 
U test (for non-normally distributed variables). The 
independent-groups t-test was used for workers 
versus controls. The bivariate relationship between 
variables under study was assessed using the Spearman 
correlation coefficient. Statistical significance was set 
at p  <  0.05. Multiple regression analysis was used to 
predict markers of oxidative stress in EBC by a set of 
predictors (Fe exposure—yes/no, age, smoking—yes/
no, alcohol consumption – yes/no, BMI, SO2, NOx, O3). 
All analyses were conducted using SPSS version 22.0 
(SPSS, Inc., Chicago, IL).
3. Results
3.1. Subjects
There were no differences in age, BMI, prevalence 
of smoking and alcohol consumption in the groups 
studied (all p  >  0.05, data not shown).
3.2. Analysis of oxidative stress markers in EBC and 
urine
As shown in figures 1 and 2, almost all markers of 
oxidation of lipids, nucleic acids, and proteins in 
the EBC (MDA, HNE, HHE, C6–C10, 8-isoprostane, 
8-OHdG, 8-OHG, 5-OHMeU, 3-ClTyr, 3-NOTyr, 
o-Tyr) were elevated (all p  <  0.001), including C11 
(p  <  0.05) in workers compared with control subjects. 
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Only aldehyde C12 was not increased. There was no 
difference in EBC conductivity and pH (5.40  ±  0.17; 
5.30  ±   0.08) between workers and controls, 
respectively. There was no difference between the pH 
of the smokers and controls, either.
In workers, no positive correlation was found 
between EBC markers and age, lifestyle factors (smok-
ing, alcohol intake) and presence of disease including 
rhinitis and chronic bronchitis. No correlation was 
found between the presence of markers (both EBC and 
urine) and sample collection time.
On the other hand, markers of oxidative stress in 
urine were not significantly different in workers and 
controls. Slightly elevated levels of C6, C7 and C9 in 
workers did not reach statistical significance. However, 
correlations were observed between several EBC and 
urine markers of oxidative stress. Among them, MDA, 
C6 and C9 urine concentration correlated with EBC lev-
Figure 1. Malondialdehyde (MDA), 4-hydroxy-trans-hexenale (HHE), 4-hydroxy-trans-nonenale (HNE), 8-isoProstaglandin 
F2α (8-isoprostane, 8-iso), 8-hydroxy-2-deoxyguanosine (8-OHdG), 8-hydroxyguanosine (8-OHG), hydroxymethyl uracil 
(5-OHMeU), o-tyrosine (o-Tyr), 3-chlorotyrosine (3-ClTyr), and nitrotyrosine (3-NOTyr) in the exhaled breath condensate (EBC) 
of iron oxide exposed workers and controls. The symbols *** denote the significance levels of data equivalency gained from the 
workers and controls (p  <  0.001). The bars denote the confidence levels (p  =  0.05).
Figure 2. Aldehydes C6–C12 in the exhaled breath condensate (EBC) in iron oxides exposed workers and controls. The symbols ***, 
**, denote the significance levels of data equivalency gained from the workers and controls. *** (p  <  0.001) **(p  <  0.01). The bars 
denote the confidence levels (p  =  0.05).
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els of the same markers. Additionally, C6 in EBC corre-
lated with HNE, C7–C10, and OHdG in urine, and C9 in 
EBC correlated with all other urine markers (p  <  0.05).
3.3. Workplace aerosol measurements
Total workshop aerosol concentrations varied greatly 
in both time and space. Median mass concentration 
in the production unit of the plant was 0.083 mg m−3 
(IQR 0.063–0.133 mg m−3) and the particle number 
concentration was 66,800 particles cm−3 (IQR 16 900–
86 900 particles cm−3).
The mass concentration at the calcination furnace 
(0.069 mg m−3 (IQR 0.061–0.083 mg m−3)) was lower 
than that at the drying unit (0.136 mg m−3 (IQR 0.079–
0.236 mg m−3)). However, the calcination furnace had a 
higher particle number concentration (86 100 particles 
cm−3 (IQR 80 000–103 000 particles cm−3)) than the 
drying unit (15 900 particles cm−3 (IQR 13 000–22 700 
particles cm−3)).
Surprisingly, the operating room had the high-
est mass concentration (0.243 mg m−3 (IQR 
0.175–0.311 mg m−3)) but an average particle number 
concentration (34 100 particles cm−3 (25 900–42 800 
particles cm−3)).
Median particle size distributions (during one 
work-shift) at each of the three locations (control room, 
calcination furnace and dryer) were measured by SMPS 
(figure 3) and APS (figure 4) spectrometers.
The highest particle number concentrations meas-
ured by SMPS (14–710 nm) were found near the cal-
cination furnace, where the highest value ~3  ×  105 
particles cm−3 was found at smallest detectable par-
ticle sizes. This suggests there were many particles 
smaller than 14 nm at this location. This corresponds 
Figure 3. Median particle size distributions (PSD) in the control room, near the exit of the calcination furnace and near the dryer. 
Measurements were obtained by SMPS (14–350 nm) during three work-shifts.
Figure 4. Median particle size distributions in the control room, near the exit of the calcination furnace, and near the dryer. 
Measurements were obtained by APS (0.5–10 μm) during three work-shifts.
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to a gas-to-particle conversion process whereby gas-
eous precursors react to form less volatile reaction 
products that condense to form new particles. At the 
calcination furnace, particle number concentration 
decreased as particle size increased. The concentra-
tion of 55 nm particles at the calcination furnace was 
lower than in the control room and correspondingly, 
the concentration of particles  >70 nm was lowest at 
the calcination furnace. Surprisingly, in the accumu-
lation peak at ~100 nm, the highest particle number 
concentration (~5  ×  104 particles cm−3) was found 
in the control room. This indicates that there was a 
separate source of accumulation peak particles and 
these particles were not transferred to other parts of 
the production plant. We can only speculate about the 
nature of these particles. The lowest concentrations 
were found at the dryer with a maximum concentra-
tion of approximately 2  ×  104 particles cm−3. The 
PSD was broad and flat with two detectable peaks at 
30 and 70 nm that likely reflected particles that were 
transported from other parts of the production plant; 
however these peaks were not much higher that of 
background (ambient air).
Median particle number size distributions deter-
mined by the APS spectrometer (0.5–10 μm) are shown 
in figure 4. All three PSD were decreased as particle size 
increased. The highest particle number concentrations 
were found at the dryer and were ~2  ×  higher than 
corresp onding concentrations at the calcination fur-
nace. The PSD with the steepest curve was from the con-
trol room and the smallest APS size was ~2  ×  higher 
than at the dryer. These particles likely came from the 
same source as those from the upper size of the spectra 
measured by SMPS (figure 3). At the right end of the 
particle size axis in figure 4, control room PSD was more 
than an order of magnitude lower than at the dryer and 
in the calcination furnace area. The explanation for the 
much steeper decline of the PSD is simple: the surface 
to volume ratio of the control room was by far the high-
est of all three locations; therefore, the deposition of 
particles on surfaces was greatest.
It is worth noting that at any part of the plant, the 
medium dust concentration did not exceed the national 
allowed concentration of 10 mg m−3 for inert dust.
3.4. Raman spectra of dust sediment
Raman spectra of dust sediment samples are shown 
in figure 5. Raman spectra of samples 1, 2, 4 and 
5 show the presence of α-Fe2O3 with significant 
bands at 227 cm−1, 298 cm−1 and 414 cm−1 and 
the presence of Fe3O4 with a significant band at 
1322 cm−1 [34]. Samples 1 and 2 were found during 
red pigment production with a minor presence of 
Fe3O4. The Raman spectrum of sample 3 collected 
during the production of yellow pigment, shows 
bands at 240 cm−1, 296 cm−1, 395 cm−1, 476 cm−1, 
543 cm−1 and 678 cm−1, consistent with the presence 
of FeO(OH) [34]. Raman spectra of samples 4 and 5 
show a mixture of α-Fe2O3 and Fe3O4, consistent with 
brown pigment components.
3.5. Environmental air contamination
The level of air pollution with SO2, NOx, O3, PM2.5 
and PM10 at both sites was classified by the National 
Figure 5. Raman spectra of dust sediment samples from the workplace. Red dust: samples 1, 2; yellow dust: sample 3; brown dust: 
sample 4; brown-red dust: sample 5.
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Hydrometeorological monitoring system as very 
low or low (data not shown). No values exceeded the 
recommended limits.
3.6. Association of EBC markers with occupational 
exposure
The multiple regression analysis confirmed a 
significant association between occupational exposure 
and the concentration of all markers of oxidative 
stress in EBC, as shown in tables 1–3. Age, BMI, 
lifestyle and environmental parameters were not 
positively associated, with the exception of O3 with 
HNE and 8-isoprostane. Surprisingly, some markers 
of environmental pollution were negatively correlated 
with EBC markers, for example with SO2 with 
8-isoprostane, C6, C8, C9 and 8-OHG.
Table 1. Multiple regression analysis (regression coefficient and 95% CI) of Fe oxides exposure, age, smoking, alcohol, body mass index 
(BMI), environmental air contamination and markers of oxidation of lipids, malondialdehyde (MDA), 4-hydroxy-trans-hexenale (HHE), 
4-hydroxy-trans-nonenale (HNE), 8-isoProstaglandin F2α (8-isoprostane, 8-iso) in the exhaled breath condensate. 
MDA HHE HNE 8-isoprostane
Fe exposure (Yes/No) 10.05b 14.58c 7.91a 10.16b
(3.36, 16.74) (10.65, 18.50) (1.48, 14.34) (4.68, 15.65)
Age (years) −0.11 −0.04 −0.01 0.14
(−0.34, 0.11) (−0.17, 0.10) (−0.23, 0.20) (−0.05, 0.32)
Smoking (Yes/No) 1.36 1.11 −3.52 −2.24
(−3.46, 6.19) (−1.72, 3.94) (−8.16, 1.11) (−6.20, 1.72)
Alcohol (Yes/No) −1.91 1.69 0.80 −1.42
(−13.07, 9.26) (−4.86, 8.25) (−9.93, 11.52) (−10.58, 7.74)
BMI (kg m−2) −0.08 −0.23 0.04 0.19
(−0.63, 0.48) (−0.55, 0.10) (−0.49,−0.57) (−0.27, 0.64)
SO2 (μg m−3) 0.02 0.00 0.03 −0.13a
(−0.10, 0.14) (−0.07, 0.07) (−0.09, 0.14) (−0.23,−0.03)
NOx (μg m−3) −0.01 0.01 −0.05 0.00
(−0.08, 0.06) (−0.03, 0.06) (−0.12, 0.02) (−0.06, 0.06)
O3 (μg m−3) −0.14 −0.03 0.15a 0.17b
(−0.01, 0.28) (−0.12, 0.05) (0.01, 0.29) (0.06, 0.29)
a (p  <  0.05), 
b (p  <  0.01), and 
c (p  <  0.001).
Table 2. Multiple regression analysis (regression coefficient and 95% CI) of Fe oxides exposure, age, smoking, alcohol, BMI and 
environmental air contamination and aldehydes C6-C11 in the exhaled breath condensate.
C6 C7 C8 C9 C10 C11
Fe exposure (Yes/No) 2.75c 1.47a 2.15c 2.50c 1.96c 0.04b
(1.94, 3.56) (0.21, 2.72) (1.37, 2.93) (1.94, 3.06) (1.33, 2.59) (0.02, 0.07)
Age (years) 0.01 0.00 −0.01 0.01 0.00 0.00
(−0.01, 0.04) (−0.05, 0.04) (−0.04, 0.01) (0.00, 0.03) (−0.02, 0.02) (0.00, 0.00)
Smoking (Yes/No) −0.36 −0.01 0.13 −0.10 −0.01 −0.01
(−0.94, 0.23) (−0.92, 0.89) (−0.43, 0.69) (−0.50, 0.31) (−0.47, 0.44) (−0.02,−0.01)
Alcohol (Yes/No) −0.66 0.88 0.38 0.21 −0.07 0.01
(−2.01, 0.69) (−1.21, 2.97) (−0.93, 1.68) (−0.72, 1.14) (−1.12, 0.97) (−0.03, 0.06)
BMI (kg m−2) −0.06 0.01 0.00 −0.03 −0.01 0.00
(−0.12, 0.01) (−0.09, 0.11) (−0.07, 0.06) (−0.07, 0.02) (−0.06, 0.04) (0.00, 0.00)
SO2 (μg m−3) −0.03b 0.01 −0.02a −0.02c −0.01 0.00
(−0.04,−0.01) (−0.02, 0.03) (−0.03, 0.00) (−0.03,−0.01) (−0.02, 0.00) (0.00, 0.00)
NOx (μg m−3) 0.00 0.00 0.00 0.00 0.00 0.00
(−0.01, 0.01) (−0.01, 0.01) (−0.01, 0.01) (0.00, 0.01) (−0.01, 0.01) (0.00, 0.00
O3 (μg m−3) 0.00 0.01 0.01 0.00 0.00 0.00
(−0.02, 0.01) (−0.02, 0.03) (−0.01, 0.02) (−0.01, 0.01) (−0.01, 0.01) (0.00, 0.00)
a ( p  <  0.05), 
b ( p  <  0.01), and 
c ( p  <  0.001).
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4. Discussion
To the best of our knowledge, this study examining 
oxidative stress markers in iron oxide workers exposed 
to nanoparticles is the first of its kind in the occupational 
medicine field. Although workers did not complain of 
any symptoms, the presence of oxidative stress markers 
in the EBC of workers compared with controls shows a 
biological effect of nanoparticle exposure.
In a recent review, Lewinski et al [2] analysed 
results from both occupational exposure studies 
and controlled human volunteer inhalation studies. 
However, no occupational study focused on nanopar-
ticle exposure. Additionally, these studies had poorly 
defined criteria for iron oxide aerosol exposure. 
In the volunteer studies, Fe2O3 or Fe3O4 iron oxide 
particles with diameters ranging from 1–6 μm were 
used. Volunteer inhalational studies confirmed two 
phases of clearance: a fast phase (several days) repre-
senting mucociliary clearance in the tracheobronchial 
tree, and a slow phase (several years) representing 
macrophage clearance in the alveolar region. This is 
in agreement with the slow disappearance (reduction 
in size and profusion) of x-ray opacities in welders due 
to the recovery of retained iron oxide particles. Weld-
ing fumes are classified as possibly carcinogenic for 
humans (group 2B) by the International for Research 
on Cancer (IARC) [35]. It is important to mention 
that welding leads to the formation of nanoparticles 
and iron represents about 80–95% wt% of welding 
fumes. However, co-exposure with known carcino-
gens, such as asbestos, chromium ad nickel may be the 
most plausible explanation for the elevated cancer risk 
in welders.
Our study suggests adverse biological effects from 
inhalational occupational exposure to aerosol contain-
ing a high proportion of nano-sized iron oxide particles. 
This study supports our data from a pilot study where 
workers were exposed to nano-aerosol during titanium 
oxide (TiO2) white pigment production. The results 
showed that markers of lipids, protein and nucleic acid 
oxidation were highly elevated (p ˂ 0.001) in the EBC 
of workers both pre-shift and post-shift [36, 37]. It was 
also found that the elimination of TiO2 particles from 
airways was rather slow, as they were still present in 40% 
of pre-shift EBC samples from workers, i.e. from the 
previous shift or shifts [38]. Also many experimental 
studies using TiO2 particles document the biological 
effect of their nano form [39].
Iron oxides and TiO2 both have low solubility and 
in the bulk form, they have a low systemic toxicity in 
humans. In nano iron oxide workers, oxidative stress 
markers in EBC were elevated; however, the total mass 
concentrations did not exceed the permissible exposure 
limit (PEL) for iron oxide particles, the occupational 
safety and health association (OSHA) limit for iron 
oxides fumes (10 mg m−3 time weighted average TWA 
concentration) [40] or the National Institute for Occu-
pational Safety and Health (NIOSH) recommended 
exposure limit of 5 mg m−3 TWA [41]. The limits, how-
ever, have not been designed for iron nanoparticles.
Additionally, it should be mentioned, that oxidative 
stress and inflammation markers in EBC were elevated 
in patients previously exposed to carcinogenic inor-
ganic dusts [29], silica [42] and asbestos [43] which can 
contain up to 30% iron [44].
Urinalysis of oxidative stress markers was also 
performed in this study to evaluate potential systemic 
Table 3. Multiple regression analysis (regression coefficient and 95% CI) of Fe oxides exposure, age, smoking, alcohol, BMI and 
environmental air contamination and markers of oxidation of nucleic acids and proteins, 8-hydroxy-2-deoxyguanosine (8-OHdG), 
8-hydroxyguanosine (8-OHG), hydroxymethyl uracil (5-OHMeU), o-tyrosine (o-Tyr), 3-chlorotyrosine (3-ClTyr), and nitrotyrosine 
(3-NOTyr) in the exhaled breath condensate.
8-OHdG 8-OHG 5-OHMeU o-Tyr 3-ClTyr 3-NOTyr
Fe exposure (Yes/No) 12.20b 20.93b 9.94b 7.98a 12.70b 29.78b
(6.00, 18.40) (15.91, 25.94) (5.61, 14.28) (2.84, 13.12) (7.53, 17.87) (16.46, 43.10)
Age (years) 0.05 0.02 0.06 0.09 0.04 0.03
(−0.15, 0.26) (−0.14, 0.19) (−0.09, 0.20) (−0.08, 0.27) (−0.14, 0.21) (−0.42, 0.48)
Smoking (Yes/No) 0.30 0.10 −0.77 −1.47 −1,79 1.18
(−4.18, 4.77) (−3.52, 3.71) (−3.90, 2.36) (−5.18, 2.24) (−5.52, 1.93) (−8.43, 10.79)
Alcohol (Yes/No) 4.95 −3.26 −3.86 −2.52 0.68 0.36
(−5.40, 15.30) (−11.63, 5.11) (−11.10, 3.38) (−11.11, 6.06) (−7.95, 9.30) (−21.88, 22.59)
BMI (kg m−2) −0.27 0.02 −0.03 −0.11 −0.26 −0.81
(−0.79, 0.24) (−0.39, 0.44) (−0.39, 0.33) (−0.54, 0.31) (−0.68,−0.17) (−1.91,−0.29)
SO2 (μg m−3) 0.01 −0.16a −0.08 0.00 −0.05 −0.14
(−0.10, 0.12) (−0.25,−0.07) (−0.15, 0.00) (−0.10,−0.09) (−0.15, 0.04) (−0.38, 0.10)
NOx (μg m−3) 0.00 0.00 −0.01 −0.04 0.02 −0.06
(−0.07, 0.06) (−0.06, 0.05) (−0.06, 0.03) (−0.09, 0.02) (−0.03, 0.08) (−0.20, 0.09)
O3 (μg m−3) 0.01 −0.06 −0.08 0.07 −0.05 −0.04
(−0.13, 0.14) (−0.16, 0.05) (−0.17, 0.01) (−0.04, 0.18) (−0.16, 0.06) (−0.33, 0.25)
a (p  <  0.01), and 
b (p  <  0.001).
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effects of iron oxide nanoparticles. The negative urinal-
ysis results suggest there were likely no systemic effects.
Studies on the effects of environmental pollutants 
have been described by Gong [25, 26]. After the Beijing 
Olympics, it was found that gaseous pollutants, such as 
SO2, were associated with elevated MDA and 8-OHdG 
levels in EBC and urine samples of inhabitants on the 
same day.
In our study, we did not found environmental air 
pollution to be an important factor because PM2.5 con-
centration, for instance, was about 10  ×  lower com-
pared with the results from the study by Gong et al [26]. 
Still, two markers, 8-isoprostane and HNE showed an 
effect of O3 and SO2 in the multiple regression analysis; 
however it was not stronger than the effect of occupa-
tional exposure. Therefore, these markers do not appear 
to be the best predictors of the effect of nano Fe oxides.
One limitation of this study was the low number of 
subjects, due to a small number of workers in the fac-
tory. Even with this limitation, results in this study were 
still statistically significant at a 95% confidence inter-
val. Another limitation was the fact that the chemical 
analysis of aerosol samples was not performed. There-
fore, dust sediment samples were analysed by Raman 
microspectrometry to confirm the purity of the iron 
oxides dust.
5. Conclusions
To the best of our knowledge, this is the first study to 
examine oxidative stress markers in EBC and urine in 
workers exposed to nano iron oxides. The potential 
adverse effects of nanoparticles on human health are 
not well understood and research on this subject is a 
priority for the OECD, NIOSH and European Agency 
for Safety and Health at Work [45]. The importance of 
this type of research is high not only for the construction 
and coatings industries where iron oxide nanoparticles 
are produced in the process of pigment production, 
but also for industries that produce fertilizers, catalysts, 
magnetic materials, biomedical imaging materials and 
therapeutic agents.
Exposure to iron oxide nanoparticles has been 
extensively studied in rodents and results show that 
oxidative stress and inflammatory responses occur 
after exposure; however, no human studies have been 
conducted. The elevation of oxidative stress markers in 
EBC is in agreement with experimental data and with 
mechanisms of oxidative stress, based on epidemiologi-
cal studies on major sources of carcinogenesis [46].
Based on our urinalysis results, iron oxide particle 
exposure did not result in systemic effects. However, 
this may be dependent on the level of iron oxide par-
ticle exposure.
The presence of lipid, nucleic acid and protein oxi-
dation biomarkers in the EBC of workers expanded 
our understanding of the effect of nanoparticle inha-
lation in humans. To evaluate the elimination of iron 
oxide nanoparticles from the human body, we are 
currently using Raman microspectroscopy and trans-
ition electron microscopy to further analyse EBC and 
urine samples.
Using the precautionary principle, all exposed 
employees, including research workers who are directly 
exposed to iron oxide nanoparticles should be moni-
tored for potential side effects. EBC collection and anal-
ysis is a non-invasive method for monitoring effects of 
respiratory system nanoparticle exposure and should 
be evaluated in parallel with periodic physical exami-
nations.
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